Watchmaker Genomics

Watchmaker Genomics

High-performance enzymes for genomics workflows

Overview

Watchmaker Genomics develops specialized enzymes and tailored solutions used to read, write, and edit DNA for high-growth molecular biology companies. These enzymes act as biological tools that drive critical workflows like DNA sequencing and synthesis, supported by custom manufacturing and quality control processes. The company distinguishes itself through a leadership team with deep industry experience in enzyme supply chains and a focus on creating bespoke products through collaborative research partnerships. Its goal is to accelerate genomic research and diagnostics by providing high-performance tools that improve the speed and accuracy of genetic data processing.

About Watchmaker Genomics

Simplify's Rating
Why Watchmaker Genomics is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Industrial & Manufacturing

Biotechnology

Healthcare

Company Size

201-500

Company Stage

Series A

Total Funding

$48.3M

Headquarters

Boulder, Colorado

Founded

2019

Your Connections

People at Watchmaker Genomics who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • TAPS+ supports cfDNA and FFPE oncology workflows across sequencing platforms.
  • Callisto automates PCR-free WGS library prep for mid-throughput clinical laboratories.
  • Visby and Promega partnerships expand diagnostics and RNA analysis reach.

What critics are saying

  • Large partners can absorb Watchmaker enzymes into broader product portfolios.
  • Platform-agnostic chemistry faces entrenched methylation and sequencing ecosystem lock-in.
  • Partnership-led growth leaves revenue exposed if collaborators reprioritize launches.

What makes Watchmaker Genomics unique

  • TAPS+ combines genetic and epigenetic readouts from one DNA molecule.
  • Watchmaker specializes in protein-engineered enzymes for demanding genomic workflows.
  • Its products target accuracy, efficiency, and cost-effective molecular analysis.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$48.3M

Above

Industry Average

Funded Over

2 Rounds

Series A funding typically happens when a startup has a product and some customers, and now needs funding to scale. This money is usually used to grow the team, expand marketing, and improve the product. Venture capital firms are frequently the main investors here.
Series A Funding Comparison
Above Average

Industry standards

$15M
$8.2M
Discord
$15M
Canva
$30M
Kalshi
$40M
Watchmaker Genomics

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Flexible Work Hours

Paid Parental Leave

401(k) Retirement Plan

401(k) Company Match

Employee Assistance Program

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Watchmaker Genomics
May 21st, 2026
Watchmaker Genomics recognized for Excellence in Exporting.

Watchmaker Genomics recognized for Excellence in Exporting. - May 21, 2026 BOULDER - Today, on World Trade Day, Gov. Jared Polis, Lt. Gov. Dianne Primavera and the Global Business Development Division of the Colorado Office of Economic Development and International Trade (OEDIT) announced Watchmaker Genomics, a biotechnology company developing advanced tools for genomic analysis, as the 2026 recipient of the Governor's Award for Excellence in Exporting. "Colorado is a leader in innovation and we are building a strong workforce and growing our economy. Watchmaker Genomics represents the best of Colorado innovation and is at the forefront of advanced technology, driving global advances in science and while creating jobs contributing to our thriving Colorado economy through business growth and job creation," said Governor Polis. "Colorado is proud to be home of Watchmaker Genomics. Their economic impact is felt within our state and internationally. Most importantly, the company's work is contributing to scientific progress that has the potential to improve health on a global scale. It was my honor to recognize a company that reflects the very best of Colorado," said Lt. Governor Dianne Primarvera. Based in Boulder, Colorado, Watchmaker Genomics develops advanced solutions for DNA and RNA sequencing by combining enzyme engineering with integrated workflow design. Its technologies span library preparation, amplification, and epigenomic analysis, helping researchers generate higher-quality genomic data with greater efficiency and consistency. Fueled by strong global demand for improved sequencing performance, Watchmaker Genomics has expanded its international presence to support researchers worldwide. "As demand for high-performance sequencing technologies continues to grow globally, we're proud to develop and manufacture these products in Colorado," said Trey Foskett, CEO of Watchmaker Genomics. "This award recognizes not only our international growth, but also the incredible team driving innovation and manufacturing here in Boulder." By exporting products internationally, companies like Watchmaker Genomics bring new revenue into Colorado, fuel growth and job creation, and foster reinvestment in local operations. In support of Watchmaker Genomics' expansion, OEDIT awarded the company an Advanced Industries Early Stage and Capital Retention Grant to develop novel protein engineering and manufacturing platforms. Additionally, the company received a State Trade Expansion Program (STEP) grant in 2025 to attend and exhibit at the European Human Genetics Conference, a premier annual event in Europe for professionals in the field of human genetics to build brand awareness and establish connections with new international customers. Through these opportunities, the company has established new business relationships, expanded its distribution network, and increased awareness of its groundbreaking technology among international providers. "Colorado companies are advancing new technologies sought around the globe. By supporting their efforts to export internationally, we enhance Colorado's reputation for innovation and demand for products produced in our state. We are thrilled to recognize Watchmaker Genomics' growth and contribution to Colorado's economy," said Eve Lieberman, OEDIT Executive Director. Trade supports over 820,000 jobs in the state, making international sales vital to Colorado's strong economy. In 2025, Colorado exported a record $11 billion of goods to the world. Recognizing small businesses with this award highlights opportunities for Colorado to expand its exporting capabilities and grow the state's economy. In 2023, 5,563 companies exported from Colorado locations and of those, 87% were small and medium-sized enterprises with fewer than 500 employees. Small and medium-sized firms also generated 27.2% of Colorado's total exports of goods the same year. The Governor's Award for Excellence in Exporting recognizes companies that have exported products or services outside of Colorado for two or more years, are new to international exporting, or expanding into a new market and are headquartered in or have at least 50 percent of their employees based in Colorado. Since 1970, 133 companies have won the award. About OEDIT's Global Business Development Division Global Business Development (GBD) is a division of the Colorado Office of Economic Development and International Trade. GBD supports Colorado businesses and communities by using a data-driven approach to recruit, support, and retain businesses that contribute to a robust and diversified economy. Watchmaker Genomics, Inc. align its portfolio of programs, services, and incentives with industries that benefit Colorado companies and elevate the state's national and international competitiveness. GBD also hosts foreign delegations and participates in trade and investment missions around the world to strengthen global awareness of Colorado. With a highly educated and motivated workforce, a thriving innovation economy, and nation-leading entrepreneurial spirit, Colorado is a top market for business development. About the Colorado Office of Economic Development and International Trade The Colorado Office of Economic Development and International Trade (OEDIT) works to empower all to thrive in Colorado's economy. Under the leadership of the Governor and in collaboration with economic development partners across the state, Watchmaker Genomics, Inc. foster a thriving business environment through funding and financial programs, training, consulting and informational resources across industries and regions. Watchmaker Genomics, Inc. promote economic growth and long-term job creation by recruiting, retaining, and expanding Colorado businesses and providing programs that support entrepreneurs and businesses of all sizes at every stage of growth. Its goal is to protect what makes its state a great place to live, work, start a business, raise a family, visit and retire - and make it accessible to everyone. Learn more about OEDIT.

360Dx
Apr 20th, 2026
Watchmaker Genomics takes aim at infectious disease dx with new qpcr, isothermal products at ESCMID.

Watchmaker Genomics takes aim at infectious disease dx with new qpcr, isothermal products at ESCMID. MUNICH - Watchmaker Genomics, a company known more for its engineered enzymes for use in next-generation sequencing and cancer research applications, this week showcased its newer products for infectious disease molecular diagnostics developers here at the European Society of Clinical Microbiology and Infectious Diseases global congress (ESCMID Global). Get the full story with 360dx Premium. Only $95 for the first 90 days. Full site access Interest-based email alerts Premium Access - Trial Offer $95.00 for 3 month

PR Newswire
Feb 23rd, 2026
Volta Labs and Watchmaker Genomics launch Callisto Complete Kit for automated PCR-free DNA sequencing

Volta Labs and Watchmaker Genomics have launched the Callisto Complete Kit for DNA EF Library Prep at the AGBT 2026 conference in Orlando. The solution combines Watchmaker's NGS sample preparation chemistry with Volta's digital fluidics automation to deliver fully automated, PCR-free whole genome sequencing library preparation. The kit targets clinical research and translational laboratories requiring mid-throughput solutions. PCR-free workflows minimise amplification bias and sequencing artefacts whilst enabling more uniform genome coverage, particularly in GC-rich regions. The automation eliminates manual liquid handling and reduces operator variability. "Labs can run PCR-free whole genome sequencing workflows in a push-button format, delivering consistent, high-quality results," said Udayan Umapathi, CEO of Volta Labs. The companies hosted a joint presentation at AGBT 2026 on 24 February.

Virtual Press Office
Feb 23rd, 2026
Volta Labs and Watchmaker Genomics Partner to Introduce Callisto(TM) Complete Kit for DNA EF Library Prep at AGBT 2026

Volta Labs and Watchmaker Genomics partner to introduce Callisto(TM) Complete Kit for DNA EF Library Prep at AGBT 2026. BOSTON and BOULDER, Colo., Feb. 23, 2026 /PRNewswire/ - At the Advances in Genome Biology and Technology (AGBT) General Meeting 2026 in Orlando, FL, Volta Labs, a leader in next-generation sequencing (NGS) sample preparation automation, today announced the launch of the Callisto(TM) Complete Kit for DNA EF Library Prep. The new solution pairs Watchmaker Genomics' best-in-class NGS sample preparation chemistry with Volta's digital fluidics automation to deliver a fully automated, PCR-free whole genome sequencing (WGS) library preparation workflow. As whole genome sequencing continues to expand across clinical research and translational settings, PCR-free workflows are increasingly preferred to minimize amplification bias, reduce sequencing artifacts, and enable more uniform genome coverage, particularly in GC-rich regions. However, executing PCR-free library preparation demands precision and reproducibility, making automation critical for labs seeking consistent results without increasing staffing burden. By eliminating manual liquid handling and reducing operator variability, the Callisto(TM) Complete Kit enables laboratories to generate reproducible, high-quality libraries while freeing technical staff to focus on higher-value work. "We designed Callisto to make sequencing sample preparation simpler and more accessible," said Udayan Umapathi, CEO of Volta Labs. "With the Callisto(TM) Complete Kit for DNA EF Library Prep, powered by Watchmaker chemistry, labs can run PCR-free whole genome sequencing workflows in a push-button format, delivering consistent, high-quality results in a practical mid-throughput range." "PCR-free whole genome sequencing demands both high-performance chemistry and workflow precision," said Trey Foskett, CEO of Watchmaker Genomics. "For clinical and translational laboratories that require push-button solutions with dependable performance but do not operate at a high-throughput scale, the Callisto(TM) Complete Kit offers a simple and streamlined path to implementing PCR-free WGS with confidence." To mark the launch, Volta Labs and Watchmaker Genomics will host a joint in suite presentation at AGBT 2026 on February 24 at 8:30 a.m. in the Fulton Suite, where attendees can learn more about the Callisto(TM) Complete Kit for DNA EF Library Prep, see the automated PCR-free WGS workflow in action, and hear directly from both teams. About Volta Labs Volta Labs is pioneering a new future of sequencing sample preparation by combining digital fluidics, modular workflows, and full walk-away automation in a single platform. Callisto(TM) enables high-quality, reproducible NGS library preparation for whole-genome, targeted, and custom applications. Volta Labs is headquartered in Boston, Massachusetts. About Watchmaker Genomics Watchmaker Genomics is a life sciences company focused on developing high-performance tools that empower genomic research and clinical applications. Leveraging expertise in protein engineering and next-generation sequencing, Watchmaker delivers precision reagents and platforms that enable superior accuracy, efficiency, and cost-effectiveness in molecular analysis. The company is dedicated to advancing breakthrough technologies to support innovations in cancer detection, epigenetics, and liquid biopsy applications. Media Contacts Volta Labs Nicole Ellis Ovadia Director of Strategic Marketing [email protected] Watchmaker Genomics Jen Pavlica Associate Director, Product Marketing [email protected] SOURCE Volta Labs Inc.

360Dx
Feb 5th, 2026
Visby Medical, Watchmaker Genomics Partner to Develop At-Home Respiratory Pathogen Detection Tests

Visby Medical, Watchmaker Genomics partner to develop at-home respiratory pathogen detection tests. NEW YORK - Visby Medical said on Thursday that it has inked a partnership with Watchmaker Genomics to develop diagnostic tests for detecting respiratory pathogens in the at-home setting. To read the full story...

Recently Posted Jobs

Sign up to get curated job recommendations

Watchmaker Genomics is Hiring for 10 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →